Dr. Noboru Yamamoto is leading early drug development in NCCH as well as in Japan.

Also, He is leading clinical trials as a deputy director (as research) in NCCH, and organizing translational research platform (Tsukiji TR Board) in collaboration with NCC-Research Institute.